ʻO ke Belt and Road: Ka Launa Pū, ka Lokahi a me ka Lanakila-Lanakila
nā huahana

Nā huahana

ZD-Pro-OH CAS:6404-31-5

ʻO ZD-Pro-OH, i ʻike ʻia hoʻi ʻo N-tert-butoxycarbonyl-D-proline, he hui kemika koʻikoʻi i hoʻohana nui ʻia i ka synthesis organik a me ka kemika peptide. Me ke ʻano molekala C11H17NO4, lawelawe ia ma ke ʻano he poloka kūkulu koʻikoʻi no ka synthesis peptide a me ka hoʻomohala peptidomimetic. ʻIke ʻia no kona maʻemaʻe kiʻekiʻe a me ke kūpaʻa, hoʻokani ʻo ZD-Pro-OH i kahi kuleana koʻikoʻi i ka synthesis peptide solid-phase a me solution-phase, e hiki ai ke kaohi pololei ma luna o ka stereochemistry i ka hōʻuluʻulu ʻana o nā kaʻina peptide maʻamau. Hoʻopili kāna mau noi ma nā ʻano like ʻole e like me ka noiʻi lāʻau lapaʻau, ka ʻike lāʻau, a me ka biochemistry, e lilo ia i mea waiwai nui no nā kānaka ʻepekema a me nā poʻe loea.


Nā kikoʻī huahana

Nā Lepili Huahana

Hoʻohana a me ka hopena:

Hoʻohana nui ʻia ʻo ZD-Pro-OH i ke kemika peptide no ke kūkulu ʻana i nā peptides a me nā peptidomimetics. Ma ke ʻano he derivative D-proline i pale ʻia e N-tert-butoxycarbonyl (Boc), hoʻomaʻalahi ia i ka hoʻohui ʻana o nā koena D-proline i loko o nā kaulahao peptide, e hāʻawi ana i kahi hoʻonohonoho stereochemical kū hoʻokahi me nā noi hiki ke hoʻonui i ka hana olaola a me ke kūpaʻa metabolic. Hoʻohana nā kemika a me nā mea noiʻi iā ZD-Pro-OH i ka synthesis peptide solid-phase a me solution-phase e hoʻolauna i nā motif D-proline, e hiki ai ke hoʻolālā i nā ʻano peptide hou no nā pilina i kuhikuhi ʻia me nā mea loaʻa olaola a me nā enzymes. Ma waho aʻe o kāna kuleana i ka synthesis peptide, he mea nui ʻo ZD-Pro-OH i ka hoʻomohala ʻana o nā peptidomimetics—nā molekala i hoʻolālā ʻia e hoʻohālike i nā waiwai a me nā hana o nā peptides bioactive. Ma ka hoʻohui ʻana i nā ʻāpana i loaʻa mai ZD-Pro-OH, hiki i nā kānaka ʻepekema ke ʻimi i ka hana ʻana o nā peptidomimetics me nā ʻano pharmacological like ʻole, e hoʻomākaukau ana i ke ala no nā moho lāʻau lapaʻau hou, nā probes molekala, a me nā mea hana biochemical me nā noi therapeutic a me nā noiʻi. Eia kekahi, lawelawe ʻo ZD-Pro-OH ma ke ʻano he ʻāpana koʻikoʻi i ka hana ʻana i nā lāʻau lapaʻau a me nā therapeutics e pili ana i ka peptide. ʻO kona maʻemaʻe kiʻekiʻe a me ka hilinaʻi e lilo ia i mea nui loa i ka hana ʻana i nā peptides maʻamau a me nā peptidomimetics no nā haʻawina preclinical a me nā clinical, e hāʻawi ana i nā mea noiʻi i ka maʻalahi e hana ʻenekinia i nā ʻano peptide me ka ikaika biological i hoʻonui ʻia, selectivity, a me nā waiwai pharmacokinetic. Ma keʻano holoʻokoʻa, hoʻokani ʻo ZD-Pro-OH i kahi kuleana koʻikoʻi i ka hoʻolaha ʻana i nā kahua o ka kemika peptide, ka ʻike lāʻau, a me ka hoʻomohala ʻana i nā lāʻau lapaʻau, e hāʻawi ana i nā ʻepekema a me nā mea noiʻi me nā mea hana e wehe i ka hiki o nā peptides a me nā peptidomimetics no ka hoʻoponopono ʻana i nā pilikia biological paʻakikī a me ka hoʻolaha ʻana i ka hana hou therapeutic.

Hoʻohana nui ʻia ʻo ZD-Pro-OH i ke kemika peptide no ke kūkulu ʻana i nā peptides a me nā peptidomimetics. Ma ke ʻano he derivative D-proline i pale ʻia e N-tert-butoxycarbonyl (Boc), hoʻomaʻalahi ia i ka hoʻohui ʻana o nā koena D-proline i loko o nā kaulahao peptide, e hāʻawi ana i kahi hoʻonohonoho stereochemical kū hoʻokahi me nā noi hiki ke hoʻonui i ka hana olaola a me ke kūpaʻa metabolic. Hoʻohana nā kemika a me nā mea noiʻi iā ZD-Pro-OH i ka synthesis peptide solid-phase a me solution-phase e hoʻolauna i nā motif D-proline, e hiki ai ke hoʻolālā i nā ʻano peptide hou no nā pilina i kuhikuhi ʻia me nā mea loaʻa olaola a me nā enzymes. Ma waho aʻe o kāna kuleana i ka synthesis peptide, he mea nui ʻo ZD-Pro-OH i ka hoʻomohala ʻana o nā peptidomimetics—nā molekala i hoʻolālā ʻia e hoʻohālike i nā waiwai a me nā hana o nā peptides bioactive. Ma ka hoʻohui ʻana i nā ʻāpana i loaʻa mai ZD-Pro-OH, hiki i nā kānaka ʻepekema ke ʻimi i ka hana ʻana o nā peptidomimetics me nā ʻano pharmacological like ʻole, e hoʻomākaukau ana i ke ala no nā moho lāʻau lapaʻau hou, nā probes molekala, a me nā mea hana biochemical me nā noi therapeutic a me nā noiʻi. Eia kekahi, lawelawe ʻo ZD-Pro-OH ma ke ʻano he ʻāpana koʻikoʻi i ka hana ʻana i nā lāʻau lapaʻau a me nā therapeutics e pili ana i ka peptide. ʻO kona maʻemaʻe kiʻekiʻe a me ka hilinaʻi e lilo ia i mea nui loa i ka hana ʻana i nā peptides maʻamau a me nā peptidomimetics no nā haʻawina preclinical a me nā clinical, e hāʻawi ana i nā mea noiʻi i ka maʻalahi e hana ʻenekinia i nā ʻano peptide me ka ikaika biological i hoʻonui ʻia, selectivity, a me nā waiwai pharmacokinetic. Ma keʻano holoʻokoʻa, hoʻokani ʻo ZD-Pro-OH i kahi kuleana koʻikoʻi i ka hoʻolaha ʻana i nā kahua o ka kemika peptide, ka ʻike lāʻau, a me ka hoʻomohala ʻana i nā lāʻau lapaʻau, e hāʻawi ana i nā ʻepekema a me nā mea noiʻi me nā mea hana e wehe i ka hiki o nā peptides a me nā peptidomimetics no ka hoʻoponopono ʻana i nā pilikia biological paʻakikī a me ka hoʻolaha ʻana i ka hana hou therapeutic.

Laʻana Huahana:

L-Arginine1
L-Arginine2

Hoʻopili huahana:

L-Arginin3

ʻIke Hou Aʻe:

Hoʻonohonoho ʻana C13H15NO4
Hoʻāʻo 99%
helehelena pauka keʻokeʻo
Helu CAS. 6404-31-5
Hoʻopili ʻana Liʻiliʻi a nui
Ola Papa 2 mau makahiki
Ka Waihona E mālama i kahi maloʻo a me kahi anuanu
Palapala hōʻoia ISO.

 


  • Ma mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou